secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001654954-22-008585
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica acquires Revo Squared veterinary imaging assets for $6M cash plus earn-out and warrants
--------------------------------------------------------------------------------

- Base purchase price $6M cash, subject to working capital adjustments; $500K held in escrow for 15 months.
- Up to $4M in earn-out payments based on net sales milestones ($2M each for $5M and $10M threshold) through 2027.
- Warrants to purchase 10M common shares issued at closing; exercise price tied to ZOM closing price on closing date.
- Acquisition includes MicroView digital cytology platform, an automated slide preparation and imaging system for veterinary clinics.
- Closing expected on or around July 1, 2022; Revo Squared CEO Bill Campell and Senior Director Negin Ghassemian to join Zomedica.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495422008585/0001654954-22-008585-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495422008585/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-008585

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer